Table 1.
Drug | Dose | Metabolism/Clearance | Considerations |
---|---|---|---|
Acetaminophen | <4 g/d | Hepatic | Dose adjust for cirrhosis: up to 2g/d |
Gabapentinoids Gabapentin Pregabalin |
100–1200 mgTID 50–300 mg TID |
Renal |
Dose adjust for GFR; Commonly can cause somnolence, blurry vision |
Ketamine Infusion | 2–5 mcg/kg/min | Hepatic | Avoid if history of PTSD/psychosis due to risk of hallucinations |
Lidocaine Infusion* | 1–2 mg/min | Hepatic | Avoid if history of seizure disorder, on anti-arrhythmics |
NSAIDs* | Varies | Renal | Caution with reduced GFR, peptic ulcers, age >65 |
SNRIs* | Varies | Hepatic | Analgesic effect is faster onset than anti-depressant effect; helps with anxiety component |
Note: *Not recommended for routine use by SCCM.3
Abbreviations: TID, three times daily; GFR, glomerular filtration rate; PTSD, post-traumatic stress disorder; NSAIDs, non-steroidal anti-inflammatory drugs; SNRIs, serotonin/norepinephrine reuptake inhibitors.